Filing Details
- Accession Number:
- 0001179110-17-015232
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-11 18:23:30
- Reporting Period:
- 2017-12-07
- Accepted Time:
- 2017-12-11 18:23:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1113481 | Medicines Co | MDCO | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1033409 | N Fredric Eshelman | 8 Sylvan Way Parsippany NJ 07054 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-12-07 | 100,000 | $26.46 | 1,028,383 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-12-08 | 100,000 | $26.65 | 1,128,383 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 944,537 | Indirect | See footnote |
Footnotes
- The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $26.24 to $26.60 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $26.40 to $26.81 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- These shares of the issuer's common stock are owned by Eshelman Ventures, LLC, an entity wholly owned by the reporting person.